Balyasny Asset Management L.P.

Position in PCRX — Pacira BioSciences, Inc.

CIK 1218710 Chicago, IL

Back to PCRX Full portfolio

Position in PCRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,405,046

-$22,076,890 QoQ

Shares Held

106,418

-88.8% QoQ

Ownership

0.270%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Balyasny Asset Management L.P. holds $180,059,722 across 19 Drug Manufacturers - Specialty & Generic names. PCRX ranks #11 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc.	539,382	$40,912,124
2	KNSA	Kiniksa Pharmaceuticals International, plc	499,792	$24,064,984
3	BIOA	BioAge Labs, Inc.	1,327,545	$23,218,762
4	UTHR	UNITED THERAPEUTICS Corp	36,623	$21,716,706
5	ALKS	Alkermes plc.	586,775	$20,748,363
6	AMLX	Amylyx Pharmaceuticals, Inc.	1,107,271	$15,391,066
7	AQST	Aquestive Therapeutics, Inc.	2,900,570	$12,037,365
8	PRGO	PERRIGO Co plc	804,856	$8,644,153

All Filings in PCRX

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,405,046	106,418	-88.8%	Shares	Sole	2026-05-15
2025-12-31	$24,481,936	945,979	-49.8%	Shares	Sole	2026-02-17
2025-09-30	$48,578,279	1,885,071	-11.5%	Shares	Sole	2025-11-14
2025-06-30	$50,924,518	2,130,733	+36.1%	Shares	Sole	2025-08-14
2025-03-31	$38,901,308	1,565,445	+260.5%	Shares	Sole	2025-05-15
2024-12-31	$8,180,441	434,206	-32.7%	Shares	Sole	2025-02-14
2023-06-30	$25,834,651	644,738	+2071.5%	Shares	Sole	2023-08-14
2023-03-31	$1,211,689	29,691	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.